A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class.

Eiichiro Suzuki, Shuichi Kaneko, Takuji Okusaka, Masafumi Ikeda, Kensei Yamaguchi, Rie Sugimoto, Takeshi Aramaki, Akinori Asagi, Kohichiroh Yasui, Keiji Sano, Ayumu Hosokawa, Naoya Kato, Hiroshi Ishii, Tosiya Sato, Junji Furuse

Japanese journal of clinical oncology

2018/04

10.1093/jjco/hyy010